Vagus nerve stimulation to reduce pain and improve nerve function in diabetic neuropathy
Official title: Effect of Vagus Nerve Stimulation on Pain Intensity, Nerve Conduction Studies and Functional Outcomes in Diabetic Peripheral Neuropathy Patients
Run by Cairo University · NCT07405021 · Data updated 2026-11-12
This test tries non-invasive transcutaneous vagus nerve stimulation to reduce foot pain and improve nerve conduction and function in people aged 45–60 with diabetic peripheral neuropathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 60 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Damietta) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | March 1, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT07405021 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45–60 with a history of diabetes longer than five years, symptomatic glove‑and‑stocking numbness or burning pain in the feet, HbA1c between 6.5% and 7%, and the ability to walk independently are the intended participants.
✕Probably not a fit
People with pacemakers or other implanted electrical devices, significant cardiac arrhythmias, other neuromuscular disorders, active foot ulcers or major foot deformities, uncontrolled diabetes, or those outside the 45–60 age range are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Thirty adults with diabetic peripheral neuropathy will be enrolled at the outpatient clinic of the Faculty of Physical Therapy, Horus University (Damietta) and receive either transcutaneous auricular vagus nerve stimulation, sham stimulation, or a conventional physical therapy program. Pain intensity, neuropathic symptom severity, nerve conduction studies, and functional outcome measures will be collected before and after the intervention period. The study compares real stimulation against sham and standard therapy to see whether tVNS provides greater reductions in pain and objective improvements in nerve function. Safety and tolerability, including cardiac contraindications, will also be monitored throughout the protocol.
Why it matters
Potential benefit: If successful, this could provide a non-drug option to reduce neuropathic pain, improve nerve function, and help people with diabetic neuropathy better perform daily activities.
How similar studies have gone: Small pilot studies of vagus nerve stimulation for some chronic pain syndromes have shown promising but inconsistent results, and robust evidence specifically for diabetic neuropathy is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Thirty patients diagnosed with diabetic neuropathy of both genders. * Age range between 45 and 60 years. * Presence of numbness and/or pain in the feet with no other identifiable cause. * Pain characterized as stabbing, electric shock-like, or burning in nature. * Presence of glove-stocking sensory changes and abnormal sensations in the distal lower limbs. * Ability to ambulate independently without assistance. * Patients under full medical control. * Hemoglobin A1c levels ranging from 6.5% to 7%. * History of diabetes mellitus for more than 5 years. Exclusion Criteria * Implantation of cardiac pacemakers or other electrical stimulation devices. * Presence of sinus bradycardia, sick sinus syndrome, or other cardiac arrhythmias. * Lumbar radiculopathy. * Psychiatric or mental disorders or history of seizures. * Visual or auditory impairments or tremors affecting balance. * Presence of other neuromuscular disorders. * Foot deformities or active foot ulcers. * History of lower limb surgical operations.
Where it's running
-
outpatient clinic, faculty of physical therapy, Horus university
Damietta, Egypt Recruiting
Study contacts
- Study coordinator: Hoda Mamdouh nematallah, assisstant lecturer
- Email: hmamdouh@horus.edu.eg
- Phone: 01096551775
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Foot-ankle exercises plus mindful walking for people with diabetic polyneuropathy
This trial will test whether adding a 12-week foot-ankle exercise program to mindful walking reduces foot/ankle pain and improves function and quality of life for adults (40–75) with diabetic polyneuropathy who can walk independently.
-
Transcutaneous Vagal Nerve Stimulation to help with brain vessel narrowing after aneurysm rupture
This trial tests whether using a noninvasive nerve stimulation device can reduce cerebral vasospasm after an aneurysmal brain bleed in adults 18–65 who are undergoing standard treatment.
-
Peripheral magnetic stimulation plus balance training to reduce falls in diabetic polyneuropathy
This trial will test whether adding peripheral magnetic stimulation to balance training helps people with diabetic polyneuropathy reduce their risk of falling.
-
Ultrasound of leg nerves linked to walking and balance in adults with type 2 diabetes
The study will use ultrasound to measure lower-leg nerves and see if nerve changes relate to walking, balance, pain, and daily activity in adults with type 2 diabetes and peripheral neuropathy.
-
Improving driving safety for patients with diabetic neuropathy
This study is testing a new visual feedback tool to help people with diabetic neuropathy drive more safely by improving how they use the accelerator pedal.
-
Early angioplasty for diabetic foot syndrome
This study is testing if getting a quick angioplasty after being diagnosed with diabetic foot ulcers helps heal the wounds better than waiting for the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.